CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,841,401
+$2,571,660 QoQ
Shares Held
877,643
+5.3% QoQ
Ownership
0.827%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CRNX ranks #46 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,841,401 | 877,643 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,269,741 | 833,418 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,401,215 | 781,981 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $32,430,855 | 778,652 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $22,036,717 | 766,228 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,273,295 | 753,527 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $38,814,112 | 759,126 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $33,491,859 | 655,418 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $26,741,824 | 597,049 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,400,082 | 478,532 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $16,735,871 | 470,373 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,719,151 | 461,303 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,320,298 | 350,738 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,549,806 | 345,567 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,277,906 | 343,055 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,602,771 | 336,190 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,185,664 | 331,671 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,543,843 | 298,125 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,231,371 | 289,735 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,699,349 | 223,247 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,693,110 | 195,921 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,303,490 | 150,752 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,126,701 | 150,723 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,301,468 | 146,871 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,364,744 | 134,974 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $775,013 | 52,722 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||